Mendez, MF, Shapira, JS, McMurtray, A, Licht, E, Miller, BL. Accuracy of the clinical evaluation for frontotemporal dementia. Archives of Neurology 2007;64(6):830–5.Google Scholar

Chow, TW, Pio, FJ, Rockwood, K. An international needs assessment of caregivers for frontotemporal dementia. The Canadian Journal of Neurological Sciences. Le Journal Canadien des Sciences Neurologiques 2011;38(5):753–7.Google ScholarPubMed

Rascovsky, K, Hodges, JR, Knopman, D, Mendez, MF, Kramer, JH, Neuhaus, J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain: A Journal of Neurology 2011;134(Pt 9):2456–77.CrossRefGoogle ScholarPubMed

Gorno-Tempini, ML, Hillis, AE, Weintraub, S, Kertesz, A, Mendez, M, Cappa, SF, et al. Classification of primary progressive aphasia and its variants. Neurology 2011;76(11):1006–14.Google Scholar

Mioshi, E, Hsieh, S, Savage, S, Hornberger, M, Hodges, JR. Clinical staging and disease progression in frontotemporal dementia. Neurology 2010;74(20):1591–7.Google Scholar

Woolley, JD, Khan, BK, Murthy, NK, Miller, BL, Rankin, KP. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. The Journal of Clinical Psychiatry 2011;72(2):126–33.Google Scholar

Wylie, MA, Shnall, A, Onyike, CU, Huey, ED. Management of frontotemporal dementia in mental health and multidisciplinary settings. International Review of Psychiatry 2013;25(2):230–6.Google Scholar

Mesulam, MM, Wieneke, C, Thompson, C, Rogalski, E, Weintraub, S. Quantitative classification of primary progressive aphasia at early and mild impairment stages. Brain: A Journal of Neurology 2012;135(Pt 5):1537–53.CrossRefGoogle ScholarPubMed

Diehl-Schmid, J, Schmidt, EM, Nunnemann, S, Riedl, L, Kurz, A, Forstl, H, et al. Caregiver burden and needs in frontotemporal dementia. Journal of Geriatric Psychiatry and Neurology 2013;26(4):221–9.Google Scholar

Onyike, CU, Diehl-Schmid, J. The epidemiology of frontotemporal dementia. International Review of Psychiatry 2013;25(2):130–7.Google ScholarPubMed

Hodges, JR, Davies, R, Xuereb, J, Kril, J, Halliday, G. Survival in frontotemporal dementia. Neurology 2003;61(3):349–54.CrossRefGoogle ScholarPubMed

Borroni, B, Grassi, M, Archetti, S, Papetti, A, Del Bo, R, Bonvicini, C, et al. Genetic background predicts poor prognosis in frontotemporal lobar degeneration. Neuro-degenerative Diseases 2011;8(5):289–95.Google Scholar

Le Rhun, E, Richard, F, Pasquier, F. Natural history of primary progressive aphasia. Neurology 2005;65(6):887–91.CrossRefGoogle ScholarPubMed

Borroni, B, Benussi, A, Cosseddu, M, Archetti, S, Padovani, A. Cerebrospinal fluid tau levels predict prognosis in non-inherited frontotemporal dementia. Neuro-degenerative Diseases 2014;13(4):224–9.Google Scholar

Salmon, E, Perani, D, Collette, F, Feyers, D, Kalbe, E, Holthoff, V, et al. A comparison of unawareness in frontotemporal dementia and Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry 2008;79(2):176–9.CrossRefGoogle ScholarPubMed

The Association for Frontotemporal Degeneration [cited December 2013]. Available from: www.theaftd.org.Google Scholar

Jicha, GA. Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies. Journal of Molecular Neuroscience: MN 2011;45(3):713–23.Google Scholar

Knopman, DS, Kramer, JH, Boeve, BF, Caselli, RJ, Graff-Radford, NR, Mendez, MF, et al. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain: A Journal of Neurology 2008;131(Pt 11):2957–68.CrossRefGoogle ScholarPubMed

Sapolsky, D, Bakkour, A, Negreira, A, Nalipinski, P, Weintraub, S, Mesulam, MM, et al. Cortical neuroanatomic correlates of symptom severity in primary progressive aphasia. Neurology 2010;75(4):358–66.CrossRefGoogle ScholarPubMed

Dickerson, BC. Quantitating severity and progression in primary progressive aphasia. Journal of Molecular Neuroscience: MN 2011;45(3):618–28.Google Scholar

de Simone, V, Kaplan, L, Patronas, N, Wassermann, EM, Grafman, J. Driving abilities in frontotemporal dementia patients. Dementia and Geriatric Cognitive Disorders 2007;23(1):1–7.CrossRefGoogle ScholarPubMed

Manoochehri, M, Huey, ED. Diagnosis and management of behavioral issues in frontotemporal dementia. Current Neurology and Neuroscience Reports 2012;12(5):528–36.Google Scholar

Huey, ED, Putnam, KT, Grafman, J. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology 2006;66(1):17–22.Google Scholar

O'Brien, JT, Burns, A, BAP Dementia Consensus Group. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology. Journal of Psychopharmacology 2011;25(8):997–1019.CrossRefGoogle ScholarPubMed

Parashos, SA, Wielinski, CL, Giladi, N, Gurevich, T. Falls in Parkinson disease: analysis of a large cross-sectional cohort. Journal of Parkinson's Disease 2013;3(4):515–22.Google Scholar

Maher, AR, Maglione, M, Bagley, S, Suttorp, M, Hu, JH, Ewing, B, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA: The Journal of the American Medical Association 2011;306(12):1359–69.Google Scholar

Steinberg, M, Lyketsos, CG. Atypical antipsychotic use in patients with dementia: managing safety concerns. The American Journal of Psychiatry 2012;169(9):900–6.Google Scholar

Devanand, DP, Schultz, SK, Sultzer, DL. Discontinuation of risperidone in Alzheimer's disease. The New England Journal of Medicine 2013;368(2):187–8.Google Scholar

Lopez-Pousa, S, Calvo-Perxas, L, Lejarreta, S, Cullell, M, Melendez, R, Hernandez, E, et al. Use of antidementia drugs in frontotemporal lobar degeneration. American Journal of Alzheimer's Disease and Other Dementias 2012;27(4):260–6.Google Scholar

Kerchner, GA, Tartaglia, MC, Boxer, A. Abhorring the vacuum: use of Alzheimer's disease medications in frontotemporal dementia. Expert Review of Neurotherapeutics 2011;11(5):709–17.Google Scholar

Boxer, AL, Knopman, DS, Kaufer, DI, Grossman, M, Onyike, C, Graf-Radford, N, et al. Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurology 2013;12(2):149–56.CrossRefGoogle ScholarPubMed

Vercelletto, M, Boutoleau-Bretonniere, C, Volteau, C, Puel, M, Auriacombe, S, Sarazin, M, et al. Memantine in behavioral variant frontotemporal dementia: negative results. Journal of Alzheimer's Disease: JAD 2011;23(4):749–59.CrossRefGoogle ScholarPubMed

van Balken, I, Litvan, I. Current and future therapeutic approaches in progressive supranuclear palsy. Handbook of Clinical Neurology 2008;89:493–508.Google Scholar

Boeve, BF, Josephs, KA, Drubach, DA. Current and future management of the corticobasal syndrome and corticobasal degeneration. Handbook of Clinical Neurology 2008;89:533–48.CrossRefGoogle ScholarPubMed

Constantinescu, R, Richard, I, Kurlan, R. Levodopa responsiveness in disorders with parkinsonism: a review of the literature. Movement Disorders: Official Journal of the Movement Disorder Society 2007;22(15):2141–8; quiz 295.Google Scholar

Diniz, BS, Machado-Vieira, R, Forlenza, OV. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatric Disease and Treatment 2013;9:493–500.CrossRefGoogle ScholarPubMed

ClinicalTrials.gov: A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration [updated June 18, 2010; cited December 12, 2013]. Available from: https://clinicaltrials.gov/show/NCT00703677.Google Scholar

ClinicalTrials.gov: Effects of Tolcapone on Frontotemporal Dementia [updated October 18, 2011; cited December 12, 2013]. Available from: https://www.clinicaltrials.gov/ct2/show/NCT00604591.Google Scholar

Finger, EC. New potential therapeutic approaches in frontotemporal dementia: oxytocin, vasopressin, and social cognition. Journal of Molecular Neuroscience: MN 2011;45(3):696–701.Google Scholar

Jesso, S, Morlog, D, Ross, S, Pell, MD, Pasternak, SH, Mitchell, DG, et al. The effects of oxytocin on social cognition and behaviour in frontotemporal dementia. Brain: A Journal of Neurology 2011;134(Pt 9):2493–501.Google Scholar

ClinicalTrials.gov: Safety Study of Intranasal Oxytocin in Frontotemporal Dementia [cited May 2012]. Available from: https://clinicaltrials.gov/ct2/show/NCT01386333.Google Scholar

Achi, EY, Rudnicki, SA. ALS and frontotemporal dysfunction: a review. Neurology Research International 2012;2012:806306.CrossRefGoogle ScholarPubMed

Buchanan, JA, Christenson, A, Houlihan, D, Ostrom, C. The role of behavior analysis in the rehabilitation of persons with dementia. Behavior Therapy 2011;42(1):9–21.Google Scholar

Croot, K, Nickels, L, Laurence, F, Manning, M. Impairment- and activity/participation-directed interventions in progressive language impairment: clinical and theoretical issues. Aphasiology 2009;23(2):125–60.Google Scholar

Taylor, C, Kingma, RM, Croot, K, Nickels, L. Speech pathology services for primary progressive aphasia: exploring an emerging area of practice. Aphasiology 2009;23(2):161–74.CrossRefGoogle Scholar

Khayum, B, Wieneke, C, Rogalski, E, Robinson, J, O'Hara, M. Thinking outside the stroke: treating primary progressive aphasia (PPA). Perspectives on Gerontology 2012;17(2):37–49.Google Scholar

Reich, SG, Grill, SE. Corticobasal degeneration. Current Treatment Options in Neurology 2009;11(3):179–85.CrossRefGoogle ScholarPubMed

Nunnemann, S, Kurz, A, Leucht, S, Diehl-Schmid, J. Caregivers of patients with frontotemporal lobar degeneration: a review of burden, problems, needs, and interventions. International Psychogeriatrics/IPA 2012;24(9):1368–86.CrossRefGoogle ScholarPubMed

Denny, SS, Morhardt, D, Gaul, JE, Lester, P, Andersen, G, Higgins, PJ, et al. Caring for children of parents with frontotemporal degeneration: a report of the AFTD Task Force on Families With Children. American Journal of Alzheimer's Disease and Other Dementias 2012;27(8):568–78.Google Scholar

Banks, SJ, Weintraub, S. Neuropsychiatric symptoms in behavioral variant frontotemporal dementia and primary progressive aphasia. Journal of Geriatric Psychiatry and Neurology 2008;21(2):133–41.Google Scholar

Banks, SJ, Weintraub, S. Generalized and symptom-specific insight in behavioral variant frontotemporal dementia and primary progressive aphasia. The Journal of Neuropsychiatry and Clinical Neurosciences 2009;21(3):299–306.Google Scholar

Chancellor, B, Duncan, A, Chatterjee, A. Art therapy for Alzheimer's disease and other dementias. Journal of Alzheimer's Disease: JAD 2014;39(1):1–11.Google Scholar

Brodaty, H, Arasaratnam, C. Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. The American Journal of Psychiatry 2012;169(9):946–53.CrossRefGoogle ScholarPubMed

Shnall, A, Agate, A, Grinberg, A, Huijbregts, M, Nguyen, MQ, Chow, TW. Development of supportive services for frontotemporal dementias through community engagement. International Review of Psychiatry 2013;25(2):246–52.Google Scholar

Riedijk, SR, De Vugt, ME, Duivenvoorden, HJ, Niermeijer, MF, Van Swieten, JC, Verhey, FR, et al. Caregiver burden, health-related quality of life and coping in dementia caregivers: a comparison of frontotemporal dementia and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2006;22(5–6):405–12.Google Scholar

Gitlin, LN, Winter, L, Dennis, MP, Hodgson, N, Hauck, WW. Targeting and managing behavioral symptoms in individuals with dementia: a randomized trial of a nonpharmacological intervention. Journal of the American Geriatrics Society 2010;58(8):1465–74.CrossRefGoogle ScholarPubMed

Selwood, A, Johnston, K, Katona, C, Lyketsos, C, Livingston, G. Systematic review of the effect of psychological interventions on family caregivers of people with dementia. Journal of Affective Disorders 2007;101(1–3):75–89.Google Scholar

Cooper, C, Mukadam, N, Katona, C, Lyketsos, CG, Ames, D, Rabins, P, et al. Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia. International Psychogeriatrics/IPA 2012;24(6):856–70.CrossRefGoogle ScholarPubMed

Mioshi, E, McKinnon, C, Savage, S, O'Connor, CM, Hodges, JR. Improving burden and coping skills in frontotemporal dementia caregivers : a pilot study. Alzheimer Disease and Associated Disorders 2013;27(1):84–6.CrossRefGoogle ScholarPubMed

Wong, CC, Wallhagen, MI. Family caregivers of individuals with frontotemporal dementia: examining the relationship between coping and caregiver physical and mental health. Journal of Gerontological Nursing 2014;40(1):30–40.CrossRefGoogle ScholarPubMed

Dowling, GA, Merrilees, J, Mastick, J, Chang, VY, Hubbard, E, Moskowitz, JT. Life enhancing activities for family caregivers of people with frontotemporal dementia. Alzheimer Disease and Associated Disorders 2014;28(2):175–81.Google Scholar

Chow, TW, Fridhandler, JD, Binns, MA, Lee, A, Merrilees, J, Rosen, HJ, et al. Trajectories of behavioral disturbance in dementia. Journal of Alzheimer's Disease: JAD 2012;31(1):143–9.Google Scholar

Gallagher, MM, McLean, A, Wilson, R. Discussion of Hospice and End-of-Life Symptoms in FTD. Phoenix, Arizona: Hospice of the Valley, 2011.Google Scholar

Van den Berg, JP, Kalmijn, S, Lindeman, E, Veldink, JH, de Visser, M, Van der Graaff, MM, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology 2005;65(8):1264–7.Google Scholar